Igbp1 is part of a positive feedback loop in stem cell factor-dependent, selective mRNA translation initiation inhibiting erythroid differentiation.

Stem cell factor (SCF)-induced activation of phosphoinositide-3-kinase (PI3K) is required for transient amplification of the erythroblast compartment. PI3K stimulates the activation of mTOR (target of rapamycin) and subsequent release of the cap-binding translation initiation factor 4E (eIF4E) from the 4E-binding protein 4EBP, which controls the recruitment of structured mRNAs to polysomes. Enhanced expression of eIF4E renders proliferation of erythroblasts independent of PI3K. To investigate which mRNAs are selectively recruited to polysomes, we compared SCF-dependent gene expression between total and polysome-bound mRNA. This identified 111 genes primarily subject to translational regulation. For 8 of 9 genes studied in more detail, the SCF-induced polysome recruitment of transcripts exceeded 5-fold regulation and was PI3K-dependent and eIF4E-sensitive, whereas total mRNA was not affected by signal transduction. One of the targets, Immunoglobulin binding protein 1 (Igbp1), is a regulatory subunit of protein phosphatase 2A (Pp2a) sustaining mTOR signaling. Constitutive expression of Igbp1 impaired erythroid differentiation, maintained 4EBP and p70S6k phosphorylation, and enhanced polysome recruitment of multiple eIF4E-sensitive mRNAs. Thus, PI3K-dependent polysome recruitment of Igbp1 acts as a positive feedback mechanism on translation initiation underscoring the important regulatory role of selective mRNA recruitment to polysomes in the balance between proliferation and maturation of erythroblasts.

[1]  O. Larsson,et al.  Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors. , 2007, Cancer research.

[2]  P. Gruppuso,et al.  Subunit composition and developmental regulation of hepatic protein phosphatase 2A (PP2A). , 2007, Archives of biochemistry and biophysics.

[3]  C. Proud.  Signalling to translation: how signal transduction pathways control the protein synthetic machinery. , 2007, The Biochemical journal.

[4]  N. Sonenberg,et al.  Epigenetic Activation of a Subset of mRNAs by eIF4E Explains Its Effects on Cell Proliferation , 2007, PloS one.

[5]  T. Prickett,et al.  The α4 Regulatory Subunit Exerts Opposing Allosteric Effects on Protein Phosphatases PP6 and PP2A* , 2006, Journal of Biological Chemistry.

[6]  H. Beug,et al.  ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells. , 2006, Cancer cell.

[7]  Shaoxia Zhu,et al.  mED2--a novel gene involved in mouse embryonic development. , 2006, Yi chuan xue bao = Acta genetica Sinica.

[8]  J. Bishop,et al.  Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells. , 2006, The Journal of endocrinology.

[9]  Raffaele Fronza,et al.  Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis. , 2006, Carcinogenesis.

[10]  Hongyue Dai,et al.  Rosetta error model for gene expression analysis , 2006, Bioinform..

[11]  A. Yoshimura,et al.  Involvement of a Novel Q-SNARE, D12, in Quality Control of the Endomembrane System* , 2006, Journal of Biological Chemistry.

[12]  M. Kozak.  A second look at cellular mRNA sequences said to function as internal ribosome entry sites , 2005, Nucleic acids research.

[13]  Steven P. Gygi,et al.  mTOR and S6K1 Mediate Assembly of the Translation Preinitiation Complex through Dynamic Protein Interchange and Ordered Phosphorylation Events , 2005, Cell.

[14]  Guido Marcucci,et al.  The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein. , 2005, Cancer cell.

[15]  G. Grech,et al.  Translation Initiation Factor 4E Inhibits Differentiation of Erythroid Progenitors , 2005, Molecular and Cellular Biology.

[16]  E. Solary,et al.  Essential role for the p110δ isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia , 2005 .

[17]  S. Eddy,et al.  Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. , 2005, Genes & development.

[18]  M. Murakami,et al.  Distinct Signaling Events Downstream of mTOR Cooperate To Mediate the Effects of Amino Acids and Insulin on Initiation Factor 4E-Binding Proteins , 2005, Molecular and Cellular Biology.

[19]  Jane Y. Wu,et al.  An erythroid differentiation-specific splicing switch in protein 4.1R mediated by the interaction of SF2/ASF with an exonic splicing enhancer. , 2005, Blood.

[20]  A. Khwaja,et al.  PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kB, MAPkinase and p53 pathways , 2005, Leukemia.

[21]  E. Solary,et al.  Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia. , 2005, Blood.

[22]  Laura A. Solt,et al.  The PP2A-Associated Protein α4 Is an Essential Inhibitor of Apoptosis , 2004, Science.

[23]  C. Cutler,et al.  Mammalian target of rapamycin inhibition as therapy for hematologic malignancies , 2004, Cancer.

[24]  B. Habermann,et al.  Translational Control of Putative Protooncogene Nm23-M2 by Cytokines via Phosphoinositide 3-Kinase Signaling* , 2004, Journal of Biological Chemistry.

[25]  M. Bjornsti,et al.  The tor pathway: a target for cancer therapy , 2004, Nature Reviews Cancer.

[26]  J. Graff,et al.  eIF-4E expression and its role in malignancies and metastases , 2004, Oncogene.

[27]  P. Vogt,et al.  An essential role for protein synthesis in oncogenic cellular transformation , 2004, Oncogene.

[28]  H. Beug,et al.  Btk Is Required for an Efficient Response to Erythropoietin and for SCF-controlled Protection against TRAIL in Erythroid Progenitors , 2004, The Journal of experimental medicine.

[29]  H. Beug,et al.  FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1 , 2004, The Journal of cell biology.

[30]  M. Birnbaum,et al.  The PP2A-associated protein alpha4 is an essential inhibitor of apoptosis. , 2004, Science.

[31]  J. Licht,et al.  Aberrant Eukaryotic Translation Initiation Factor 4E-Dependent mRNA Transport Impedes Hematopoietic Differentiation and Contributes to Leukemogenesis , 2003, Molecular and Cellular Biology.

[32]  S. Carotta,et al.  Cooperative signaling between cytokine receptors and the glucocorticoid receptor in the expansion of erythroid progenitors: molecular analysis by expression profiling. , 2003, Blood.

[33]  N. Socci,et al.  Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. , 2003, Molecular cell.

[34]  L. Cantley,et al.  Targeting the PI3K-Akt pathway in human cancer: rationale and promise. , 2003, Cancer cell.

[35]  R. Colbran,et al.  Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase 2A family (PP2A(C), PP4(C), and PP6(C)) and analysis of the interaction of PP2A(C) with alpha4 protein. , 2003, Protein expression and purification.

[36]  J. Blenis,et al.  Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb , 2003, Current Biology.

[37]  K. Inoki,et al.  Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. , 2003, Genes & development.

[38]  J. Cheong,et al.  Constitutive phosphorylation of Akt/PKB protein in acute myeloid leukemia: its significance as a prognostic variable , 2003, Leukemia.

[39]  S. Sugano,et al.  Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. , 2003, Oncogene.

[40]  A. Krainer,et al.  Decrease in hnRNP A/B expression during erythropoiesis mediates a pre‐mRNA splicing switch , 2002, The EMBO journal.

[41]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[42]  S. Hanash,et al.  Global and Specific Translational Control by Rapamycin in T Cells Uncovered by Microarrays and Proteomics* , 2002, The Journal of Biological Chemistry.

[43]  A. Kornblihtt,et al.  Alternative splicing: multiple control mechanisms and involvement in human disease. , 2002, Trends in genetics : TIG.

[44]  Hong Wu,et al.  Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  H. Beug,et al.  Leukemic transformation of normal murine erythroid progenitors: v- and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis , 2001, Oncogene.

[46]  H. Beug,et al.  Establishment of normal, terminally differentiating mouse erythroid progenitors: molecular characterization by cDNA arrays , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  G. Meroni,et al.  Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit α4 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Gingras,et al.  Regulation of translation initiation by FRAP/mTOR. , 2001, Genes & development.

[49]  H. Beug,et al.  Translation control: bridging the gap between genomics and proteomics? , 2001, Trends in biochemical sciences.

[50]  美仁 長谷山.  Phosphatidylinositol 3-Kinase Is Involved in the Protection of Primary Cultured Human Erythroid Precursor Cells From Apoptosis , 2001 .

[51]  E. Sontag.  Protein phosphatase 2A: the Trojan Horse of cellular signaling. , 2001, Cellular signalling.

[52]  M. Hidalgo,et al.  The rapamycin-sensitive signal transduction pathway as a target for cancer therapy , 2000, Oncogene.

[53]  A. Balmain,et al.  TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G1 arrest , 2000 .

[54]  H. Mano,et al.  Stem cell factor induces phosphatidylinositol 3'-kinase-dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells. , 2000, Blood.

[55]  Z. Zhao,et al.  Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways , 2000, British journal of haematology.

[56]  C. Hanson,et al.  Erythroid Cells Rendered Erythropoietin Independent by Infection with Friend Spleen Focus-Forming Virus Show Constitutive Activation of Phosphatidylinositol 3-Kinase and Akt Kinase: Involvement of Insulin Receptor Substrate-Related Adapter Proteins , 2000, Journal of Virology.

[57]  G. Thomas,et al.  Ribosomal S6 kinase signaling and the control of translation. , 1999, Experimental cell research.

[58]  C. Kellendonk,et al.  The glucocorticoid receptor is required for stress erythropoiesis. , 1999, Genes & development.

[59]  A. Thomson,et al.  Iron-regulatory proteins, iron-responsive elements and ferritin mRNA translation. , 1999, The international journal of biochemistry & cell biology.

[60]  A. Geballe,et al.  Translational Control by an Upstream Open Reading Frame in the HER-2/neu Transcript* , 1999, The Journal of Biological Chemistry.

[61]  S. Gygi,et al.  Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. , 1999, Genes & development.

[62]  S. Schreiber,et al.  Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[63]  A. Gingras,et al.  eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. , 1999, Annual review of biochemistry.

[64]  A. De Benedetti,et al.  eIF4E expression in tumors: its possible role in progression of malignancies. , 1999, The international journal of biochemistry & cell biology.

[65]  H. Sanjo,et al.  Ig receptor binding protein 1 (alpha4) is associated with a rapamycin-sensitive signal transduction in lymphocytes through direct binding to the catalytic subunit of protein phosphatase 2A. , 1998, Blood.

[66]  J. Avruch,et al.  Amino Acid Sufficiency and mTOR Regulate p70 S6 Kinase and eIF-4E BP1 through a Common Effector Mechanism* , 1998, The Journal of Biological Chemistry.

[67]  A. Gingras,et al.  The mRNA 5' cap-binding protein eIF4E and control of cell growth. , 1998, Current opinion in cell biology.

[68]  Jun Wu,et al.  B cell receptor-associated protein α4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A , 1997 .

[69]  O. Gavet,et al.  KIS Is a Protein Kinase with an RNA Recognition Motif* , 1997, The Journal of Biological Chemistry.

[70]  R. Pearson,et al.  Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k , 1997, The EMBO journal.

[71]  H. Lodish,et al.  Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[72]  T. Haystead,et al.  PHAS proteins as mediators of the actions of insulin, growth factors and cAMP on protein synthesis and cell proliferation. , 1997, Advances in enzyme regulation.

[73]  D. Brautigan,et al.  B cell receptor-associated protein alpha4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[74]  K. Arndt,et al.  Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases. , 1996, Genes & development.

[75]  V. Broudy,et al.  Interaction of stem cell factor and its receptor c-kit mediates lodgment and acute expansion of hematopoietic cells in the murine spleen. , 1996, Blood.

[76]  T. Schüpbach,et al.  cornichon and the EGF receptor signaling process are necessary for both anterior-posterior and dorsal-ventral pattern formation in Drosophila , 1995, Cell.

[77]  M. Mumby,et al.  Comparison of heterotrimeric protein phosphatase 2A containing different B subunits. , 1994, The Journal of biological chemistry.

[78]  N. Sonenberg,et al.  mRNAs containing extensive secondary structure in their 5′ non‐coding region translate efficiently in cells overexpressing initiation factor eIF‐4E. , 1992, The EMBO journal.

[79]  Marieke,et al.  Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: characterization of the set gene , 1992, Molecular and cellular biology.

[80]  R. Perry,et al.  Oligopyrimidine tract at the 5' end of mammalian ribosomal protein mRNAs is required for their translational control. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[81]  M. Kozak,et al.  Effects of intercistronic length on the efficiency of reinitiation by eucaryotic ribosomes. , 1987, Molecular and cellular biology.

[82]  J. Hershey,et al.  Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F. , 1987, The Journal of biological chemistry.

[83]  M. Greaves,et al.  Modern Trends in Human Leukemia VII , 1987, Haematology and Blood Transfusion / Hämatologie und Bluttransfusion.

[84]  T. Graf,et al.  ts-oncogene-transformed erythroleukemic cells: a novel test system for purifying and characterizing avian erythroid growth factors. , 1987, Haematology and blood transfusion.

[85]  H. Zentgraf,et al.  Hormone-dependent terminal differentiation in vitro of chicken erythroleukemia cells transformed by ts mutants of avian erythroblastosis virus , 1982, Cell.